Małgorzata Lenartowicz Selected Research

Menkes Kinky Hair Syndrome (Menkes Disease)

1/2017	Copper therapy reduces intravascular hemolysis and derepresses ferroportin in mice with mosaic mutation (Atp7amo-ms): An implication for copper-mediated regulation of the Slc40a1 gene expression.
1/2015	Mottled Mice and Non-Mammalian Models of Menkes Disease.
1/2014	Haemolysis and perturbations in the systemic iron metabolism of suckling, copper-deficient mosaic mutant mice - an animal model of Menkes disease.
2/2012	Mutation in the CPC motif-containing 6th transmembrane domain affects intracellular localization, trafficking and copper transport efficiency of ATP7A protein in mosaic mutant mice--an animal model of Menkes disease.
1/2012	Prenatal treatment of mosaic mice (Atp7a mo-ms) mouse model for Menkes disease, with copper combined by dimethyldithiocarbamate (DMDTC).
1/2011	Alterations in the expression of the Atp7a gene in the early postnatal development of the mosaic mutant mice (Atp7a mo-ms) - An animal model for Menkes disease.
8/2010	Effects of copper supplementation on the structure and content of elements in kidneys of mosaic mutant mice.
1/2004	Alternative splicing in the Atp7a gene in the Cu deficient mosaic mutation in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Małgorzata Lenartowicz Research Topics

Disease

8	Menkes Kinky Hair Syndrome (Menkes Disease) 01/2017 - 01/2004
6	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2021 - 01/2015
4	Hemolysis 10/2020 - 01/2014
2	Iron Deficiencies 01/2021 - 01/2019
1	Birth Weight (Birth Weights) 11/2018
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2011
1	Sclerosis 08/2010
1	Papillary Carcinoma 08/2010
1	Neoplasms (Cancer) 01/2010
1	Deficiency Diseases (Deficiency Disease) 01/2004

Drug/Important Bio-Agent (IBA)

11	IronIBA 01/2021 - 01/2014
8	CopperIBA 01/2017 - 01/2004
3	metal transporting protein 1 (ferroportin)IBA 01/2021 - 01/2017
2	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 10/2020 - 01/2014
2	Heme (Haem)IBA 01/2019 - 01/2017
2	Copper Transport ProteinsIBA 01/2017 - 01/2014
2	Copper-Transporting ATPasesIBA 02/2012 - 01/2010
1	Ceruloplasmin (Ferroxidase)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Adenosine Triphosphatases (ATPase)IBA 01/2017
1	hemoglobin ASIBA 01/2017
1	HepcidinsIBA 01/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	HaptoglobinsIBA 01/2014
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 02/2012
1	DimethyldithiocarbamateIBA 01/2012
1	copper adenosine triphosphateIBA 08/2010

Therapy/Procedure

4	Therapeutics 01/2019 - 01/2015